logo-loader
viewCircassia Pharmaceuticals PLC

Full interview: Circassia hires Pfizer exec as it continues transition to commerical business

Circassia Pharmaceuticals PLC's (LON:CIR) CEO Steve Harris caught up with Proactive London's Andrew Scott after news they've hired one of Pfizer’s top executives to become its first chief operating officer.

Jonathan Emms, who has held a number of senior positions at both Pfizer and GlaxoSmithKline PLC (LON:GSK), will join the respiratory drug specialist next month.

Quick facts: Circassia Pharmaceuticals PLC

Price: 20.9 GBX

LSE:CIR
Market: LSE
Market Cap: £78.41 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Circassia Pharmaceuticals PLC named herein, including the promotion by the Company of Circassia Pharmaceuticals PLC in any Content on the Site,...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Circassia Pharmaceuticals' commercial development...

Circassia Pharmaceuticals PLC's (LON:CIR) CEO Steve Harris tells Proactive London's Andrew Scott they saw strong growth in the first half of the year alongside a reduction in costs and cash outflows. Revenues for the six months ended June 30 were up 40% year-on-year at £27.9mln, with the...

on 26/9/19

RNS

Circassia Announces Board Changes

17 hours, 49 minutes ago

Holding(s) in Company

2 days, 8 hours ago

Total Voting Rights Update

6 days, 17 hours ago

Holding(s) in Company

1 week, 2 days ago

Holding(s) in Company

1 week, 3 days ago

Holding(s) in Company

1 week, 3 days ago

Holding(s) in Company

1 week, 3 days ago

Holding(s) in Company

1 week, 4 days ago

2 min read